KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 188 filers reported holding KRYSTAL BIOTECH INC in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $538,124 | +2.3% | 4,639 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $526,069 | +53.0% | 4,481 | +4.3% | 0.00% | +100.0% |
| Q1 2023 | $343,938 | -10.9% | 4,296 | -11.8% | 0.00% | 0.0% |
| Q4 2022 | $386,039 | +22.6% | 4,873 | +8.0% | 0.00% | 0.0% |
| Q3 2022 | $315,000 | +10.5% | 4,511 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $285,000 | -32.8% | 4,350 | -31.8% | 0.00% | 0.0% |
| Q1 2022 | $424,000 | -14.0% | 6,378 | -9.5% | 0.00% | 0.0% |
| Q4 2021 | $493,000 | +34.0% | 7,046 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $368,000 | -37.4% | 7,041 | -18.5% | 0.00% | -50.0% |
| Q2 2021 | $588,000 | +8.1% | 8,641 | +22.4% | 0.00% | 0.0% |
| Q1 2021 | $544,000 | +50.3% | 7,060 | +16.9% | 0.00% | +100.0% |
| Q4 2020 | $362,000 | – | 6,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |